Patent ID: 9687535
Date: 2017-06-27
CPC Classifications: A61K,C12Q,C12Y,G01N

Claim:
1. A method for treating a prion disease in a patient diagnosed with the prion disease, the method comprising administering to the patient a pharmaceutical composition that comprises digestive enzymes, wherein the digestive enzymes comprise a protease, an amylase and a lipase, whereby one or more symptoms of the prion disease are treated; wherein said patient diagnosed with the prion disease has a subnormal level of fecal chymotrypsin, wherein the one or more symptoms comprise a personality change, a psychiatric problem, lack of coordination, unsteady gait, myoclonus, an unusual sensation, insomnia, confusion, a memory problem, severe mental impairment, loss of the ability to move or speak, or a combination thereof.